The influence of gene-chronic hepatitis C virus infection on hepatic fibrosis and steatosis.

Hepatitis C Interferon lambda 3 and 4 (IFNL3/IFNL4) Microsomal triglyceride transfer protein (MTTP) Patatin-like phospholipase domain containing 3 (PNPLA3) Single nucleotide polymorphisms (SNPs) Transmembrane six superfamily member 2 (TM6SF2)

Journal

Diagnostic microbiology and infectious disease
ISSN: 1879-0070
Titre abrégé: Diagn Microbiol Infect Dis
Pays: United States
ID NLM: 8305899

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 10 10 2019
revised: 24 01 2020
accepted: 14 02 2020
pubmed: 10 3 2020
medline: 28 11 2020
entrez: 10 3 2020
Statut: ppublish

Résumé

Host single nucleotide polymorphisms (SNPs) in different genes can play a role in chronic hepatitis C virus (HCV) infection and influence the presence of hepatic fibrosis and comorbidities such as hepatic steatosis. We assessed the combined effect of SNPs in the PNPLA3, MTTP, TM6SF2, and IFNL3/IFNL4 genes in 288 Brazilian patients who were chronically infected with HCV. Hepatic fibrosis was observed in 246 (85.4%) patients and hepatic steatosis in 141 (49.0%) patients. PNPLA3 rs738409 (CG/GG) (P = 0.044) and TM6SF2 rs58542926 (CT) (P = 0.004) were alone associated with fibrosis, and PNPLA3 rs738409 (P < 0.05, in distinct genetic models) was associated with steatosis. Multiple logistic regression of each SNP combined with HCV genotype 3 infection showed that MTTP rs1800591 (GT/TT) combined with HCV genotype 3 was associated with a 6.72-fold increased chance of hepatic steatosis (P = 0.013). In the analysis of SNPs combined 2 by 2, no influence on hepatic fibrosis or steatosis was observed.

Identifiants

pubmed: 32147132
pii: S0732-8893(19)31018-1
doi: 10.1016/j.diagmicrobio.2020.115025
pii:
doi:

Substances chimiques

Carrier Proteins 0
interferon-lambda, human 0
Membrane Proteins 0
TM6SF2 protein, human 0
microsomal triglyceride transfer protein 0
Interferons 9008-11-1
Lipase EC 3.1.1.3
adiponutrin, human EC 3.1.1.3

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115025

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Mariana Cavalheiro Magri (MC)

Laboratorio de Investigacao Medica em Hepatologia por Virus (LIM-47), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR. Electronic address: mariana.magri@hc.fm.usp.br.

Caroline Manchiero (C)

Laboratorio de Investigacao Medica em Hepatologia por Virus (LIM-47), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR. Electronic address: caroline.manchiero@hc.fm.usp.br.

Thamiris Vaz Gago Prata (TVG)

Laboratorio de Investigacao Medica em Hepatologia por Virus (LIM-47), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR. Electronic address: thamirisprata@usp.br.

Arielle Karen da Silva Nunes (AKDS)

Laboratorio de Investigacao Medica em Hepatologia por Virus (LIM-47), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR. Electronic address: arielle.nunes@usp.br.

José Santos de Oliveira Junior (JS)

Laboratorio de Investigacao Medica em Hepatologia por Virus (LIM-47), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR. Electronic address: jsoliveirajr51@gmail.com.

Bianca Peixoto Dantas (BP)

Laboratorio de Investigacao Medica em Hepatologia por Virus (LIM-47), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR. Electronic address: bianca.dantas@hc.fm.usp.br.

Fátima Mitiko Tengan (FM)

Laboratorio de Investigacao Medica em Hepatologia por Virus (LIM-47), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR; Departamento de Molestias Infecciosas e Parasitarias, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.. Electronic address: fatima.tengan@usp.br.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH